about US

INVIBIO BIOMATERIAL SOLUTIONS
A WORLDWIDE INNOVATIVE LEADER

Invibio is a proven partner to medical device manufacturers and a leading provider of biomaterial solutions. Our revolutionary PEEK-OPTIMA™ polymers have 20 years of proven clinical history.  Every day our implantable PEEK polymers are used in diverse medical applications including spine, arthroscopy, joint reconstruction, trauma, dental and cranio-maxillofacial (CMF) procedures.

20

Years of proven clinical history supporting our partners to bring implantable devices to market

500+

Medical devices made with PEEK-OPTIMA Polymers cleared in the US alone

~9M

Devices using PEEK-OPTIMA Polymers that have been implanted worldwide

Invibio innovation timeline

See how PEEK-OPTIMATM polymer solutions and technologies progress in key therapeutic areas over time

1999
1999 PEEK-OPTIMA Logo

PEEK-OPTIMA™ is launched

  • PEEK-OPTIMA Natural is launched as the world’s first implantable PEEK polymer
2001
Invibio Biomaterial Solutions Logo

Invibio is formed

  • Invibio Biomaterial Solutions formed as a wholly owned subsidiary of Victrex plc to focus exclusively on the medical device market
2003
International Organization for Standardization Logo

Invibio achieves ISO Compliance

  • Invibio achieves ISO 13485 compliance (cGMP) for the manufacture of
    PEEK-OPTIMA™ polymer
2004

The first PEEK-OPTIMA™ Approval by the SFDA

  • The State Food and Drug Administration (SFDA) approves the first implantable medical device manufactured from PEEK-OPTIMA polymer in China
2005

MHLW approves the first Medical Device using PEEK-OPTIMA™

  • The first orthopaedic implant in Japan using Invibio PEEK-OPTIMA receives regulatory approval from the Japanese Ministry of Health, Labour and Welfare (MHLW)
2006

Introduction of PEEK-OPTIMA™ for Trauma

  • PEEK-OPTIMATM Ultra-Reinforced polymer introduced for Trauma, an alternative to metal for use in load bearing medical device applications

First ANVISA approval of a PEEK-OPTIMA device

  • Brazilian Health Surveillance Agency (ANVISA) approves the first implantable medical device that uses PEEK-OPTIMA polymer

Frost & Sullivan Product Innovation of the Year Award

  • Invibio receives prestigious 2005 Product Innovation of the Year Award for polymeric materials in the medical implant market from Frost & Sullivan
2007

New PEEK-OPTIMA™ Image Contrast Product

  • Introduction of PEEK-OPTIMA Image Contrast polymer that allows optimal device and healing site visualization with X-ray, CT and MRI imaging modalities

Launch of PEEK-OPTIMA Reinforced

  • PEEK-OPTIMA™ Reinforced compound introduced to offer enhanced strength, wear properties and imaging capability for load bearing applications

Invibio Global Technical Center Opens

  • Invibio opens a dedicated Global Technical Center in the UK. The center houses processing facilities, testing laboratories and a Class 10,000 clean room, ensuring contaminate-free manufacturing capabilities for research and development grades as well as prototype materials and application components
2009

Spine Technology Award

  • Invibio receives Spine Technology Award in biomaterial category in recognition of its PEEK-OPTIMA™ Natural polymer

New Tribology PEEK-OPTIMA Grade

  • Invibio introduces PEEK-OPTIMA™ Wear Performance polymer, with properties specifically tailored for articulating and bearing applications against hard counterfaces
2011

Medical Design Excellence Award (MDEA)

  • Invibio is honored by MDEA in recognition to being a vital supplier to the winning Cranial LOOP from NEOS Surgery SL

New Manufacturing Facilities Open

  • Invibio opens new, dedicated manufacturing facilities to extend production capabilities at its UK Global Technology Center
2012

JUVORA™ Ltd. is formed

  • JUVORA Ltd. is formed, championing the use of non-metal alternatives in JUVORA dental prosthetics

PEEK-OPTIMA™ devices implanted milestone

  • Four million devices made with PEEK-OPTIMA implanted worldwide1

Invibio launches new brand identity

  • New corporate and divisional brands are launched by Invibio

1. Data on file at Invibio

2013

Regulatory milestones

  • Invibio reaches a regulatory milestone with the number of cleared devices using PEEK-OPTIMA™ polymers, over 500 in the US and more than 80 in China1

PEEK-OPTIMA HA Enhanced is launched

  • PEEK-OPTIMA HA Enhanced polymer is launched, demonstrating earlier bone ongrowth and greater new bone formation for interbody fusion2

International PEEK Meeting

  • Invibio supports the First International Implantable PEEK meeting with almost 50 presentations and posters

1. Data on file at Invibio
2. Study evaluated the in vivo response to PEEK-OPTIMA Natural, PEEK-OPTIMA HA Enhanced and allograft in a cervical spine fusion model in sheep. Data on file at Invibio. This has not been correlated with human clinical experience.

2014

PEEK-OPTIMA™ HA Enhanced Regulatory Milestones

  • PEEK-OPTIMA HA Enhanced receives the first US FDA 510(k) clearance for a cervical Interbody Fusion Device and the first CE mark approval for a cervical and lumbar interbody fusion device

PEEK-OPTIMATM Ultra-Reinforced is introduced

  • PEEK-OPTIMA Ultra-Reinforced is introduced as a high-performance, polymer –based, trauma device technology for internal fracture fixation

1. This product is not cleared for implantation or distribution.

2015

Spinal Stabilization System launched in China

  • Spinal Stabilization System launched in China, made with PEEK-OPTIMA™ semi-rigid spinal rods

PEEK-OPTIMATM HA Enhanced adoption momentum continues

  • First human implantation of Cervical Interbody Fusion (IBF) device
  • First US FDA 510(k) clearance for Lumbar IBF device

Number of PEEK-OPTIMA devices implanted continues to grow

  • Five million devices made with PEEK-OPTIMA implanted worldwide1

1. Data on file at Invibio
2. This product is not cleared for implantation or distribution.

2016

Invibio and Maxx Orthopedics collaborate on knee-replacement technology

  • Invibio Knee Ltd, a subsidiary of Invibio partners with Maxx Orthopedics, Inc. to develop a PEEK-OPTIMA™ femoral knee1 replacement

1. PEEK-OPTIMA femoral knee product is in the pre-market phase.

2017

JUVORA™ dental disc receives US FDA 510(k) clearance for long-term implant borne prosthetics

  • Using CAD/CAM workflows, the JUVORA implant prosthetic frameworks can be tailor-made to the patients’ specific needs.

PEEK-OPTIMA™ devices implanted milestone

  • ~9 million devices made with PEEK-OPTIMA™ implanted worldwide1

Invibio partners with UK Olympic sprinter, James Ellington, after a severe tibia fracture

  • With an Intramedullary Nail made from PEEK-OPTIMA™ Ultra-Reinforced James Ellington is working towards competing professionally again

1. Data on file at Invibio

2019

JUVORA™ CAD/CAM dental disc, with new Oyster White color, launched in US

  • Provides dental professionals the choice of working with a whiter and brighter high-performance polymer solution that is FDA 510(k) cleared

PEEK-OPTIMA™ HA Enhanced expanded use in lower extremities

  • First foot and ankle implant made from PEEK-OPTIMA™ HA Enhanced receives FDA 510(k) clearance1

1. Image provided courtesy of Nvision Biomedical Technologies.

Invibio Careers: Join Our Global Team

Invibio Biomaterial Solutions, a Victrex company, is seeking talented and passionate individuals to join our growing team of professionals. We are committed to our mission of revolutionizing patient lives by delivering clinically and commercially proven outcomes for implantable medical devices made from our revolutionary PEEK-OPTIMA™ polymers. We value innovation, hard work and a focus on helping our clients succeed. Our fast-paced, forward-looking and ambitious culture offers a dynamic place to work.

See our open positions

Receive the latest clinical evidence and data for PEEK-OPTIMA based applications


By completing this form you are signing up for marketing updates. You will receive targeted messages such as newsletters, tradeshow, webinar and event announcements from Invibio, a member of the Victrex Group. You can unsubscribe at any time. Visit our Privacy Policy to learn more.
The materials on this site are intended for Health Care Professionals and industry users only. If you are a patient, click here, otherwise, click continue.